Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 14, 2005

View Archived Issues

AstraZeneca: second quarter highlights

NBI-59159: Novel EAAT3 preferring inhibitor from Wyeth

New data on the efficacy of sitaxsentan in PAH

A-778193 reduced food intake and body weight via GHS-R antagonism

MicroIslet and Scripps Research Institute extend diabetes collaboration

Epitan obtains ethics approval for phase II study of EPT-1647 for PMLE

Encouraging outcomes for pilot study of Aerosurf delivered via nasal CPAP

In vitro and in vivo data on novel HIV integrase inhibitor

Accera receives approval for Ketasyn extension study

ImClone to use Medarex's UltiMAb system to develop human antibody products

Zonagen awards contracts for studies of Proellex and Androxal

Daiichi and GE Healthcare team up on non-nuclear contrast media

New insulin secretagogues for diabetes reported in recent Takeda patent

Recent patents cover novel therapeutics for anxiety, depression, etc.

Novel therapeutics for cardiovascular diseases reported

Ularitide has beneficial clinical effects in decompensated heart failure patients

BL-1020 targets GABA hypoactivity and dopamine overactivity for schizophrenia

Neuronal Kv7 channels: new targets for anxiolytics

New DPP-IV inhibitor highlighted as a therapeutic candidate for type 2 diabetes

New clinical evidence supports using oral insulin spray to improve glycemic control in diabetics

Priority review for Pegasys plus ribavirin in Japan

BXL-628 demonstrates efficacy in experimental autoimmune prostatitis

Nonapprovable letter for lasofoxifene in prevention of osteoporosis

Aromasin approved in Europe for adjuvant treatment of early breast cancer

Eisai submits NDA for antiepileptic agent rufinamide

ODAC recommends approval of Tarceva for pancreatic cancer

FDA committee does not recommend Xinlay

Antioxidant L-2264 ameliorates metabolic impairment in rats with insulin resistance

Data on quadrivalent human papillomavirus vaccine accumulate

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...